Home » Topics » Conferences

Conferences
RSS

BMD-188 induces tumor apoptosis in vitro and in vivo

May 27, 1998

Factor XIII does not show clinical efficacy in patients with ulcerative colitis

May 27, 1998

The role of HMG-CoA reductase inhibitors in organ transplantation

May 27, 1998

First clinical trial results reported for etomoxir in CHF

May 27, 1998

Pharmos' neuroprotectant shows additional utility in IBD and anorexia

May 26, 1998

Clinical efficacy of SB-209670 in hypertensive patients

May 26, 1998

Pharma Mar's ET-743: phase I efficacy and pharmacokinetic data reported

May 26, 1998

Glaxo Wellcome's 3622W94: phase I trial results presented at ASCO

May 26, 1998

Improved formulation of paclitaxel in development at P&U

May 26, 1998

Effects of ACE inhibition and beta-adrenoceptor blockade on intimal hypertrophy in renal Tx

May 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.